OJI  Vol.2 No.1 , March 2012
Human B7-H3 binds to Triggering receptor expressed on myeloid cells-like transcript 2 (TLT-2) and enhances T cell responses
Abstract: The B7 family member B7-H3 is broadly expressed in many tissue and tumor types. B7-H3 expression is induced on some immune cells; however, its immunological function remains controversial, because both immunoenhancing and immunoinhibitory effects have been reported in human and mouse systems. We have previously reported the following: 1) murine B7-H3 specifically bound to Triggering receptor expressed on myeloid cells (TREM)-like transcript 2 (TLT-2, TREML2), a member of the TREM family of receptors; and 2) the B7-H3:TLT-2 pathway up-regulated T cell responses. However, the expression and function of human TLT-2 has not yet been clarified. A recent study found no evidence to support the existence of an interacttion between human B7-H3 and TLT-2. In this study, we demonstrated that human B7-H3 binds to TLT-2 and augments T cell responses. Human and mouse B7-H3Ig chimeric proteins cross-interacted with both human and mouse species of TLT-2-transduced cells. Human TLT-2 was expressed on freshly isolated, peripheral blood B cells and monocytes, and subpopulations of CD4+ and CD8+ T cells. Human TLT-2 expression on T cells did not correlate with na?ve or memory phenotypes and was diminished after culture, despite the presence of mitogenic stimuli. Constitutive TLT-2 expression on monocytes was also down-regulated after culture. Human B7-H3 transfectants augment IL-2 production from TLT-2-transduced T cell hybridomas, and IFN-γ production from peripheral blood CD4+ and CD8+ T cells. The enhanced responses were inhibited by the addition of anti-TLT-2 mAbs, suggesting TLT-2-mediated costimulatory effect. Our results demonstrate the existence of a functional interaction between human B7-H3 and TLT-2, and the restricted expression of TLT-2 on T cells and monocytes.
Cite this paper: Hashiguchi, M. , Inamochi, Y. , Nagai, S. , Otsuki, N. , Piao, J. , Kobori, H. , Kanno, Y. , Kojima, H. , Kobata, T. and Azuma, M. (2012) Human B7-H3 binds to Triggering receptor expressed on myeloid cells-like transcript 2 (TLT-2) and enhances T cell responses. Open Journal of Immunology, 2, 9-16. doi: 10.4236/oji.2012.21002.

[1]   Greenwald, R.J., Freeman, G.J. and Sharpe, A.H. (2005) The B7 family revisited. Annual Review of Immunology, 23, 515-548. doi:10.1146/annurev.immunol.23.021704.115611

[2]   Bour-Jordan, H., Esensten, J.H., Martinez-Llordella, M., Penaranda, C., Stumpf, M. and Bluestone, J.A. (2011) Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family. Immunological Reviews, 241, 180-205. doi:10.1111/j.1600-065X.2011.01011.x

[3]   Zhu, Y., Yao, S. and Chen, L. (2011) Cell surface signaling molecules in the control of immune responses: A tide model. Immunity, 34, 466-478. doi:10.1016/j.immuni.2011.04.008

[4]   Chapoval, A.I., Ni, J., Lau, J.S., Wilcox, R.A., Flies, D.B., Liu, D., Dong, H., Sica, G.L., Zhu, G., Tamada, K. and Chen, L. (2001) B7-H3: A costimulatory molecule for T cell activation and IFN-γ production. Nature Immunology, 2, 269-274. doi:10.1038/85339

[5]   Ling, V., Wu, P.W., Spaulding, V., Kieleczawa, J., Luxenberg, D., Carreno, B.M. and Collins, M. (2003) Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: Divergent history of functional redundancy and exon loss. Genomics, 82, 365-377. doi:10.1016/S0888-7543(03)00126-5

[6]   Sun, M., Richards, S., Prasad, D.V., Mai, X.M., Rudensky, A. and Dong, C. (2002) Characterization of mouse and human B7-H3 genes. The Journal of Immunology, 168, 6294-6297.

[7]   Zhou, Y.H., Chen, Y.J., Ma, Z.Y., Xu, L., Wang, Q., Zhang, G.B., Xie, F., Ge, Y., Wang, X.F. and Zhang, X.G. (2007) 4IgB7-H3 is the major isoform expressed on immunocytes as well as malignant cells. Tissue Antigens, 70, 96-104. doi:10.1111/j.1399-0039.2007.00853.x

[8]   Leitner, J., Klauser, C., Pickl, W.F., Stockl, J., Majdic, O., Bardet, A.F., Kreil, D.P., Dong, C., Yamazaki, T., Zlabinger, G., Pfistershammer, K. and Steinberger, P. (2009) B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction. European Journal of Immunology, 39, 1754-1764. doi:10.1002/eji.200839028

[9]   Zhang, G.B., Dong, Q.M., Xu, Y., Yu, G.H. and Zhang, X.G. (2005) B7-H3: Another Molecule Marker for Mo-DCs? Cellular & Molecular Immunology, 2, 307-311.

[10]   Kim, J., Myers, A.C., Chen, L., Pardoll, D.M., Truong-Tran, Q.A., Lane, A.P., McDyer, J.F., Fortuno, L. and Schleimer, R.P. (2005) Constitutive and inducible expression of b7 family of ligands by human airway epithelial cells. American Journal of Respiratory Cell and Molecular Biology, 33, 280-289. doi:10.1165/rcmb.2004-0129OC

[11]   Saatian, B., Yu, X.Y., Lane, A.P., Doyle, T., Casolaro, V. and Spannhake, E.W. (2004) Expression of genes for B7-H3 and other T cell ligands by nasal epithelial cells during differentiation and activation. American Journal of Physiology Lung Cell and Molecular Physiology, 287, L217-L225. doi:10.1152/ajplung.00132.2003

[12]   Wu, C.P., Jiang, J.T., Tan, M., Zhu, Y.B., Ji, M., Xu, K.F., Zhao, J.M., Zhang, G.B. and Zhang, X.G. (2006) Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis. World Journal of Gastroenterology, 12, 457-459.

[13]   Sun, Y., Wang, Y., Zhao, J., Gu, M., Giscombe, R., Lefvert, A.K. and Wang, X. (2006) B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer, 53, 143-151. doi:10.1016/j.lungcan.2006.05.012

[14]   Roth, T.J., Sheinin, Y., Lohse, C.M., Kuntz, S.M., Frigola, X., Inman, B.A., Krambeck, A.E., McKenney, M.E., Karnes, R.J., Blute, M.L., Cheville, J.C., Sebo, T.J. and Kwon, E.D. (2007) B7-H3 ligand expression by prostate cancer: A novel marker of prognosis and potential target for therapy. Cancer Research, 67, 7893-7900. doi:10.1158/0008-5472.CAN-07-1068

[15]   Castriconi, R., Dondero, A., Augugliaro, R., Cantoni, C., Carnemolla, B., Sementa, A.R., Negri, F., Conte, R., Corrias, M.V., Moretta, L., Moretta, A. and Bottino, C. (2004) Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis. Proceedings of the National Academy of Sciences USA, 101, 12640-12645. doi:10.1073/pnas.0405025101

[16]   Chen, Y.W., Tekle, C. and Fodstad, O. (2008) The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion. Curr. Cancer Drug Targets, 8, 404-413. doi:10.2174/156800908785133141

[17]   Tran, C.N., Thacker, S.G., Louie, D.M., Oliver, J., White, P.T., Endres, J.L., Urquhart, A.G., Chung, K.C. and Fox, D.A. (2008) Interactions of T cells with fibroblast-like synoviocytes: Role of the B7 family costimulatory ligand B7-H3. Journal of Immunology, 180, 2989-2998.

[18]   Waschbisch, A., Wintterle, S., Lochmuller, H., Walter, M.C., Wischhusen, J., Kieseier, B.C. and Wiendl, H. (2008) Human muscle cells express the costimulatory molecule B7-H3, which modulates muscle-immune interactions. Arthritis & Rheumatism, 58, 3600-3608. doi:10.1002/art.23997

[19]   Yang, H.Y., Chu, M., Zheng, L.W., Zwahlen, R.A., Luo, J., Zou, D.H. and Sun, S.T. (2008) Transgenic B7-H3 therapy induces tumor-specific immune response in human oral squamous cell cancer: an in vitro study. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endod, 106, 721-728. doi:10.1016/j.tripleo.2008.08.012

[20]   Zang, X., Thompson, R.H., Al-Ahmadie, H.A., Serio, A.M., Reuter, V.E., Eastham, J.A., Scardino, P.T., Sharma, P. and Allison, J.P. (2007) B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proceedings of the National Academy of Sciences USA, 104, 19458-19463. doi:10.1073/pnas.0709802104

[21]   Crispen, P.L., Sheinin, Y., Roth, T.J., Lohse, C.M., Kuntz, S.M., Frigola, X., Thompson, R.H., Boorjian, S.A., Dong, H., Leibovich, B.C., Blute, M.L. and Kwon, E.D. (2008) Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. Clinical Cancer Research, 14, 5150-5157. doi:10.1158/1078-0432.CCR-08-0536

[22]   Katayama, A., Takahara, M., Kishibe, K., Nagato, T., Kunibe, I., Katada, A., Hayashi, T. and Harabuchi, Y. (2011) Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis. International Journal of Oncology, 38, 1219-1226. doi:10.3892/ijo.2011.949

[23]   Sun, J., Chen, L.J., Zhang, G.B., Jiang, J.T., Zhu, M., Tan, Y., Wang, H.T., Lu, B.F. and Zhang, X.G. (2011) Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. Cancer Immunology, Immunotherapy, 59, 1163-1171. doi:10.1007/s00262-010-0841-1

[24]   Yamato, I., Sho, M., Nomi, T., Akahori, T., Shimada, K., Hotta, K., Kanehiro, H., Konishi, N., Yagita, H. and Nakajima, Y. (2009) Clinical importance of B7-H3 expression in human pancreatic cancer. British Journal of Cancer, 101, 1709-1716. doi:10.1038/sj.bjc.6605375

[25]   Loos, M., Hedderich, D.M., Ottenhausen, M., Giese, N.A., Laschinger, M., Esposito, I., Kleeff, J. and Friess, H. (2009) Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer. BMC Cancer, 9, 463. doi:10.1186/1471-2407-9-463

[26]   Klesney-Tait, J., Turnbull, I.R. and Colonna, M. (2006) The TREM receptor family and signal integration. Nature Immunology, 7, 1266-1273. doi:10.1038/ni1411

[27]   Ford, J.W. and McVicar, D.W. (2009) TREM and TREM-like receptors in inflammation and disease. Current Opinion in Immunology, 21, 38-46. doi:10.1016/j.coi.2009.01.009

[28]   King, R.G., Herrin, B.R. and Justement, L.B. (2006) Trem-like transcript 2 is expressed on cells of the myeloid/ granuloid and B lymphoid lineage and is up-regulated in response to inflammation. Journal of Immunology, 176, 6012-6021.

[29]   Halpert, M.M., Thomas, K.A., King, R.G. and Justement, L.B. (2011) TLT2 potentiates neutrophil antibacterial activity and chemotaxis in response to G protein-coupled receptor-mediated signaling. Journal of Immunology, 187, 2346-2355. doi:10.4049/jimmunol.1100534

[30]   Hashiguchi, M., Kobori, H., Ritprajak, P., Kamimura, Y., Kozono, H. and Azuma, M. (2008) Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses. Proceedings of the National Academy of Sciences USA, 105, 10495-10500. doi:10.1073/pnas.0802423105

[31]   Kobori, H., Hashiguchi, M., Piao, J., Kato, M., Ritprajak, P. and Azuma, M. (2010) Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites. Immunology, 130, 363-373. doi:10.1111/j.1365-2567.2009.03236.x

[32]   Otsuki, N., Kamimura, Y., Hashiguchi, M. and Azuma, M. (2006) Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells. Biochemical and Biophysical Research Communications, 344, 1121-1127. doi:10.1016/j.bbrc.2006.03.242

[33]   Youngnak, P., Kozono, Y., Kozono, H., Iwai, H., Otsuki, N., Jin, H., Omura, K., Yagita, H., Pardoll, D.M., Chen, L. and Azuma, M. (2003) Differential binding properties of B7-H1 and B7-DC to programmed death-1. Biochemical and Biophysical Research Communications, 307, 672-677. doi:10.1016/S0006-291X(03)01257-9

[34]   Azuma, M., Cayabyab, M., Buck, D., Phillips, J.H. and Lanier, L.L. (1992) CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. The Journal of Experimental Medicine, 175, 353-360. doi:10.1084/jem.175.2.353

[35]   Zhang, G., Hou, J., Shi, J., Yu, G., Lu, B. and Zhang, X. (2008) Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum. Immunology, 123, 538-546. doi:10.1111/j.1365-2567.2007.02723.x

[36]   Sun, J., Chen, L.J., Zhang, G.B., Jiang, J.T., Zhu, M., Tan, Y., Wang, H.T., Lu, B.F. and Zhang, X.G. (2010) Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. Cancer Immunology, Immunotherapy, 59, 1163-1171. doi:10.1007/s00262-010-0841-1

[37]   Zhang, G., Xu, Y., Lu, X., Huang, H., Zhou, Y., Lu, B. and Zhang, X. (2009) Diagnosis value of serum B7-H3 expression in non-small cell lung cancer. Lung Cancer, 66, 245-249. doi:10.1016/j.lungcan.2009.01.017

[38]   Zhang, G., Wang, J., Kelly, J., Gu, G., Hou, J., Zhou, Y., Redmond, H.P., Wang, J.H. and Zhang, X. (2010) B7-H3 augments the inflammatory response and is associated with human sepsis. Journal of Immunology, 185, 3677-3684. doi:10.4049/jimmunol.0904020